Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
Nguyen, Quan Dong, Prof Dr, Merrill, Pauline T, MD, Jaffe, Glenn J, Prof, Dick, Andrew D, Prof, Kurup, Shree Kumar, Prof, Sheppard, John, MD, Schlaen, Ariel, MD, Pavesio, Carlos, MD, Cimino, Luca, MD, Van Calster, Joachim, MD, Camez, Anne A, MD, Kwatra, Nisha V, PhD, Song, Alexandra P, MD, Kron, Martina, Prof, Tari, Samir, MD, Brézin, Antoine P, Prof
Published in The Lancet (British edition) (17.09.2016)
Published in The Lancet (British edition) (17.09.2016)
Get full text
Journal Article
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
Saurat, J.-H., Stingl, G., Dubertret, L., Papp, K., Langley, R.G., Ortonne, J.-P., Unnebrink, K., Kaul, M., Camez, A.
Published in British journal of dermatology (1951) (01.03.2008)
Published in British journal of dermatology (1951) (01.03.2008)
Get full text
Journal Article
Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE
Löfberg, Robert, Louis, Edouard V., Reinisch, Walter, Robinson, Anne M., Kron, Martina, Camez, Anne, Pollack, Paul F.
Published in Inflammatory bowel diseases (01.01.2012)
Published in Inflammatory bowel diseases (01.01.2012)
Get full text
Journal Article
Web Resource
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
Revicki, D., Willian, M.K., Saurat, J.-H., Papp, K.A., Ortonne, J.-P., Sexton, C., Camez, A.
Published in British journal of dermatology (1951) (01.03.2008)
Published in British journal of dermatology (1951) (01.03.2008)
Get full text
Journal Article
THU0561 Adalimumab in Patients with Active and Inactive, Non-Infectious Uveitis: Visual I and Visual II Trials
Brézin, A.P., Dick, A.D., Jaffe, G.J., Ohno, S., Namba, K., Goto, H., Inomata, N., Song, A.P., Kron, M., Camez, A., Tari, S., Nguyen, Q.D.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
SAT0523 Adalimumab in Patients with Active, Non-Infectious Uveitis Requiring High-Dose Corticosteroids: the Visual-1 Trial
Jaffe, G.J., Thorne, J.E., Scales, D., Franco, P.J., Tari, S., Camez, A., Song, A.P., Kron, M., Barisani-Asenbauer, T., Dick, A.D.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article
Achievement of early deep remission is associated with lower rates of weekly dosing for adalimumab-treated patients with crohn's disease: data from extend
Sandborn, W J, Colombel, J F, Lomax, K G, Pollack, P F, Thakkar, R, Camez, A, Chen, N, Yang, M, Chao, J, Mulani, P M
Published in Gut (01.04.2011)
Published in Gut (01.04.2011)
Get full text
Journal Article
Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients
Vanholder, R, Camez, A, Veys, N, Van Loo, A, Dhondt, A M, Ringoir, S
Published in Thrombosis and haemostasis (01.04.1997)
Published in Thrombosis and haemostasis (01.04.1997)
Get more information
Journal Article
Recombinant hirudin: A specific thrombin inhibiting anticoagulant for hemodialysis
Vanholder, Raymond C., Camez, Anne A., Veys, Nic M., Soria, Jeannette, Mirshahi, Manouchehr, Soria, Claudine, Ringoir, Séverin
Published in Kidney international (01.06.1994)
Published in Kidney international (01.06.1994)
Get full text
Journal Article
Conference Proceeding
Mo1296 Quality of Life for Patients With Deep Remission vs. Clinical Remission and Deep Remission vs. Absence of Mucosal Ulceration: 3-Year Data From CHARM/ADHERE
Colombel, Jean-Frederic, Panaccione, Remo, Louis, Edouard, Skup, Martha, Yang, Mei, Pollack, Paul F, Thakkar, Roopal, Camez, Anne A, Chao, Jingdong, Mulani, Parvez, Sandborn, William
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2013)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2013)
Get full text
Journal Article
A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis
Schiele, F, Vuillemenot, A, Kramarz, P, Kieffer, Y, Soria, J, Soria, C, Camez, A, Mirshahi, M C, Bassand, J P
Published in Thrombosis and haemostasis (01.05.1994)
Published in Thrombosis and haemostasis (01.05.1994)
Get more information
Journal Article
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial
Louis, Edouard, Löfberg, Robert, Reinisch, Walter, Camez, Anne, Yang, Mei, Pollack, Paul F., Chen, Naijun, Chao, Jingdong, Mulani, Parvez M.
Published in Journal of Crohn's and colitis (01.02.2013)
Published in Journal of Crohn's and colitis (01.02.2013)
Get full text
Journal Article
Web Resource
Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolism
Bridey, F, Dreyfus, M, Parent, F, Bros, A, Fischer, A M, Camez, A, Simonneau, G, Duroux, P, Meyer, D
Published in American journal of hematology (01.05.1995)
Published in American journal of hematology (01.05.1995)
Get more information
Journal Article
Achievement of early deep remission is associated with lower rates of weekly dosing for adalimumab-treated patients with Crohn's disease
Sandborn, W, Colombel, J, Lomax, K, Pollack, P, Thakkar, R, Camez, A, Chen, N, Yang, M, Chao, J, Mulani, P
Published in Inflammatory bowel diseases (01.01.2011)
Published in Inflammatory bowel diseases (01.01.2011)
Get full text
Journal Article
Achievement of early deep remission predicts better long-term outcomes for adalimumab-treated patients with Crohn's disease
Sandborn, W, Colombel, J, Rutgeerts, P, Yang, M, Lomax, K, Pollack, P, Thakkar, R, Camez, A, Chen, N, Chao, J, Mulani, P
Published in Inflammatory bowel diseases (01.01.2011)
Published in Inflammatory bowel diseases (01.01.2011)
Get full text
Journal Article
Effect of disease duration on ‘deep remission’
Colombel, J, Schreiber, S, Rutgeerts, P, Sandborn, W, Yang, M, Lomax, K, Pollack, P, Thakkar, R, Camez, A, Huang, B, Zhou, Q, Mulani, P, Chao, J
Published in Inflammatory bowel diseases (01.01.2011)
Published in Inflammatory bowel diseases (01.01.2011)
Get full text
Journal Article
Adalimumab is effective for inducing clinical remission at week 4 regardless of baseline corticosteroid use
Colombel, J, Rutgeerts, P, Reinisch, W, Sandborn, W, Panés, J, Camez, A, Pollack, P, Thakkar, R, Huang, B, Yang, M, Chao, J, Mulani, P
Published in Inflammatory bowel diseases (01.01.2011)
Published in Inflammatory bowel diseases (01.01.2011)
Get full text
Journal Article